Old Web
English
Sign In
Acemap
>
authorDetail
>
Donavon McConn
Donavon McConn
Takeda Pharmaceutical Company
Chemistry
Drug
Biochemistry
Oxide
Metabolism
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 (S)-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one, by Fragment-Based Drug Design.
2021
Journal of Medicinal Chemistry
Mark Sabat
Douglas R. Dougan
Beverly Knight
J. David Lawson
Nicholas Scorah
Smith Christopher
Ewan Taylor
Phong H. Vu
Corey Wyrick
Haixia Wang
Deepika Balakrishna
Mark S. Hixon
Loui Madakamutil
Donavon McConn
Show All
Source
Cite
Save
Citations (1)
Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia
2021
Journal of Medicinal Chemistry
Holly Reichard
Hans H Schiffer
Holger Monenschein
Josephine Atienza
Gerard Corbett
Alton W Skaggs
Deanna R Collia
William J. Ray
Jordi Serrats
Joshua Bliesath
Nidhi Kaushal
Betty Lam
Alejandro Amador-Arjona
Lisa Rahbaek
Donavon McConn
Victoria J Mulligan
Nicola Brice
Philip L R Gaskin
Jackie Cilia
Stephen Hitchcock
Show All
Source
Cite
Save
Citations (2)
Downstream metabolism of a glutathione conjugate of an arene oxide intermediate
2018
Drug Metabolism and Pharmacokinetics
Steve Bowlin
Natalie Hosea
Donavon McConn
Amin Kamel
Show All
Source
Cite
Save
Citations (0)
1